CJC-1295 / Ipamorelin — 20 mg Vial

Research Use Only — Not for Human Consumption

CJC-1295 / Ipamorelin is a synthetic dual-peptide formulation supplied as a lyophilized research reference standard. This combination consists of a growth hormone–releasing hormone (GHRH) analog (CJC-1295) and a growth hormone secretagogue receptor (GHS-R) agonist (Ipamorelin), each characterized by distinct receptor-binding profiles and peptide structures.

This compound is of interest in laboratory settings for receptor-binding studies, peptide interaction analysis, and evaluation of multi-ligand signaling models. It is suitable for use in in-vitro assays, structural characterization, and analytical method development involving peptide-receptor systems.

Key Details

• Quantity: 20 mg lyophilized powder (10 mg CJC-1295 / 10 mg Ipamorelin)

• Purity: ≥ 99% (HPLC)

• Form: Sterile lyophilized peptide blend

• Appearance: White powder

• Storage: Store at –20°C or below

• Reconstitution: Sterile water for research protocols only

Certificate of Analysis (COA)

👉 View Certificate of Analysis (PDF)

Important Notice

For laboratory research use only. Not for human ingestion, diagnostic, or therapeutic use.